MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Acute chorea secondary to cephalosporin

    BED. Ines, BRA. Zeineb, MAN. Malek, ZAO. Jamel, MRI. Ridha (Tunis, Tunisia)

    Objective: To report a case of acute chorea induced by ceftriaxone and to explain neurotoxicity of antibiotics. Background: B Chorea was classically described in patients…
  • 2019 International Congress

    A Case of Secondary Myoclonic Hyperkinesia

    H. Amirjanyan, K. Harutyunyan (Nor Hach, Armenia)

    Objective: Hyperkinesias are a type of movement disorders characterized by involuntary muscle movements. There are different variants of hyperkinesia, including tremor, chorea, myoclonic movements, etc.…
  • 2019 International Congress

    The Frequency, Causes and Risk Factors of Discontinuation of Dopamine Agonists in Parkinson’s Disease Patients

    N. Durmaz çelik, M. Kuzu Kumcu, S. Bostan, E. Yiğit Tekkanat, S. özkan (Eskisehir, Turkey)

    Objective: To determine the incidence, causes and risk factors of dopamine agonists (pramipexole and ropinirole) discontinuation in Parkinson’s disease patients. Background: Ropinirole and pramipexole are…
  • 2019 International Congress

    Results of community pharmacist-led structured medication reviews in Parkinson’s Disease

    N. Oonk, P. Oude Avenhuis, K. Movig, K. Koehorst-Ter Huurne, WH. Nijmeijer, M. van Kesteren-Biegstraaten, J. Vd Palen, L. Dorresteijn (Enschede, Netherlands)

    Objective: To obtain insight in the process of community pharmacist-led structured medication reviews in patients with Parkinson’s disease (PD), by evaluating medication modifications and recommendations, and…
  • 2019 International Congress

    Depression in Parkinson’s diseaese: Experience of the neurology department in Mohammed VI third level university hospital

    H. El Yachkouri, M. Chraa, N. Kissani (Marrakesh, Morocco)

    Objective: The objectives of this study are to evaluate the frequency of depression in our Parkinson's disease patients, to describe the relationship of depression to…
  • 2019 International Congress

    Acute, contact-dependent behavioral changes in Parkinson disease (PD) patients during monopolar contact review of subthalamic deep brain stimulation (DBS) using directional leads

    CHR. Vander Linden, C. Bogaert, D. Colle, H. Colle (Ghent, Belgium)

    Objective: To describe distinctive acute behavioral changes that occurred during monopolar review in PD patients implanted with DBS directional leads, operated consecutively over 12 months.…
  • 2019 International Congress

    Functional exam findings in Lewy Body Disease

    J. Nguyen, K. Papesh (Las Vegas, NV, USA)

    Objective: Case study to review functional exam findings in an abnormal Dopaminergic transporter scan positive Lewy body dementia patient. Background: Patient presented with known Parkinson’s…
  • 2019 International Congress

    Genetic study of patients with Parkinson’s disease subjected to second line therapies

    F. Carrillo, S. Jesus, T. Periñan, R. Escuela, D. Buiza, MA. Labrador, M. Carrión, A. Adarmes, D. Macias, P. Gomez-Garre, P. Mir (Seville, Spain)

    Objective: Parkinson's disease (PD) is a neurodegenerative disorder characterized by remarkable phenotypic variability. Accumulated evidence points that the manifestation of PD clinical signs might be…
  • 2019 International Congress

    LRP10 variants and Parkinson’s disease in the Chinese population

    JN. Foo, E. Chew, M. Lian, M. Tandiono, EK. Tan (Singapore, Singapore)

    Objective: LRP10 variants have recently been identified in individuals with familial Parkinson's disease (PD) and dementia with Lewy bodies. We aim to investigate if any…
  • 2019 International Congress

    Mechanism-based classification in PD cohorts

    B. Labrador, F. Danjou, S. Bekadar, FX. Lejeune, H. Froehlich, M. Hofmann-Apitius, JC. Corvol (Paris, France)

    Objective: To stratify Parkinson’s disease (PD) patients based on key molecular mechanisms by using a genomic-based approach. Background: PD is a complex neurodegenerative disease involving…
  • « Previous Page
  • 1
  • …
  • 150
  • 151
  • 152
  • 153
  • 154
  • …
  • 217
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley